Not surprisingly, the key genes identified as frequently mutated genes in GBM—e.g., EGFR, TP53, MYC, and TERT—were present among the target genes of our set of deregulated miRNAs, highlighting the regulatory role of miRNAs in the progression of this disease. The gene discussed is MYC; the disease is glioblastoma.